Numerex Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 16, 2017 20:06 pm UTC| Business
ATLANTA, March 16, 2017 -- Numerex Corp (NASDAQ:NMRX), a leading provider of managed enterprise solutions enabling the Internet of Things (IoT), today announced financial results for its fourth quarter and year ended...
Exa Reports Fourth Quarter and Full Year Fiscal 2017 Financial Results
Mar 16, 2017 20:06 pm UTC| Business
Fourth Quarter Recurring License Revenue Increases 12%Fourth Quarter Profitability Metrics Above Guidance RangesFull Year Fiscal 2017 License Revenue Increases 14% BURLINGTON, Mass., March 16, 2017 -- Exa® Corporation...
Exa Reports Fourth Quarter and Full Year Fiscal 2017 Financial Results
Mar 16, 2017 20:06 pm UTC| Business
Fourth Quarter Recurring License Revenue Increases 12%Fourth Quarter Profitability Metrics Above Guidance RangesFull Year Fiscal 2017 License Revenue Increases 14% BURLINGTON, Mass., March 16, 2017 -- Exa® Corporation...
Mar 16, 2017 20:06 pm UTC| Business
– No new treatment-related safety or tolerability findings – – No new events reported and 15 of 15 patients event-free at 13.6 months of age; majority of patients receiving proposed therapeutic dose sit unassisted – –...
Mar 16, 2017 20:06 pm UTC| Business
– No new treatment-related safety or tolerability findings – – No new events reported and 15 of 15 patients event-free at 13.6 months of age; majority of patients receiving proposed therapeutic dose sit unassisted – –...
Intercept to Present at Upcoming Conference
Mar 16, 2017 20:06 pm UTC| Business
NEW YORK, March 16, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver...
Intercept to Present at Upcoming Conference
Mar 16, 2017 20:06 pm UTC| Business
NEW YORK, March 16, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver...